The pharmaceutical industry is poised for a transformative evolution by 2025, driven by the possibilities of emerging technologies, regulatory shifts, personalized medicine, and lessons from recent global crises. Together, these trends will redefine the pharmaceutical landscape, setting a new standard for innovation, collaboration, and patient-centered care. PM360 asked specialists about what they believe the New Year has in store for the pharmaceutical industry. We asked:
- What emerging technologies (such as AI, machine learning, etc.) are most likely to transform drug discovery and development by 2025, and what challenges might arise in integrating these innovations?
- How will regulatory policies and frameworks need to evolve to keep pace with accelerated innovation and ensure patient safety in a rapidly changing pharmaceutical landscape?
- What role will personalized medicine and targeted therapies play in shaping treatment paradigms, and how can the industry address challenges in scalability, affordability, and equitable access?
- In what ways can the pharma industry enhance its approach to supply chain resilience, especially considering the lessons learned from global crises like COVID-19?
Read more of this article from PM360
Connect With An Expert!
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…